DISCOVERIES REPORTS (ISSN 2393249X), 2021, volume 4
Access FULL text of the manuscript here: Full text (PDF)
CITATION: Kumari S, Karim HMR, Arora P, Nadirsha A. Bain’s circuit as continuous positive airway pressure device in a postoperative COVID-19 associated mucormycosis patient with type-1 respiratory failure: a case report. Discoveries Reports 2021, 4: e22. DOI: 10.15190/drep.2021.7 Submitted: June 17, 2021; Revised and Accepted: June 30, 2021; Published: June 30, 2021.
Bain’s circuit as continuous positive airway pressure device in a postoperative COVID-19 associated mucormycosis patient with type-1 respiratory failure: a case report
Snigdha Kumari (1), Habib Md Reazaul Karim (1,*), Prateek Arora (1), Arshad Nadirsha (1)
(1) Department of Anaesthesiology, Critical Care and Pain Medicine, All India Institute of Medical Sciences Raipur, India.
* Corresponding author: Habib Md Reazaul Karim, MD, DNB, IDCCM, FNIV. Faculty Room A001, Block A, AIIMS Raipur Hospital Complex, GE Road, Tatibandh, Raipur, 492099, India. Email: email@example.com
The surge in coronavirus disease of 2019 (COVID-19) pneumonia cases has brought about a wave of COVID-19 associated mucormycosis, especially in patients with diabetes and those on immunosuppressive drugs. In addition, the antifungal therapy and the residual cardiopulmonary illness bring about an array of challenges in the perioperative period. Most often, such patients are far from optimized and need urgent surgical intervention. Regardless to say, many need some form of respiratory assistance in the postoperative period as well. With the pandemic already throttling the existing resources, such as ventilators and oxygen supply, it may be prudent to use devices from an anesthetist's armamentarium to aid patient's oxygenation and ventilation in the perioperative period. The authors describe one such case using Bain's circuit and a noninvasive ventilation mask to function as a continuous positive airway pressure device.
1. Ibrahim AS, Spellberg B, Walsh TJ, et al. Pathogenesis of mucormycosis. Clin Infect Dis. 2012 ;54 Suppl 1(Suppl 1):S16-22. doi: 10.1093/cid/cir865.
2. Tahaghoghi-Hajghorbani S, Zafari P, Masoumi E, et al. The role of dysregulated immune responses in COVID-19 pathogenesis. Virus Res. 2020;290:198197. doi: 10.1016/j.virusres.2020.198197.
3. John TM, Jacob CN, Kontoyiannis DP. When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis. J Fungi (Basel). 2021;7(4):298. doi: 10.3390/jof7040298.
4. Rabagliati R, Rodríguez N, Núñez C, et al. COVID-19–Associated Mold Infection in Critically Ill Patients, Chile. Emerg Infect Dis. 2021;27(5):1454-1456.
5. Brunet K, Rammaert B. Mucormycosis treatment: Recommendations, latest advances, and perspectives. J Mycol Med. 2020;30(3):101007. doi: 10.1016/j.mycmed.2020.101007.
6. Takazono T, Tashiro M, Ota Y, et al. Factor analysis of acute kidney injury in patients administered liposomal amphotericin B in a real-world clinical setting in Japan. Sci Rep. 2020;10(1):15033.
7. Arora P, Pourafkari L, Visnjevac O, et al. Preoperative serum potassium predicts the clinical outcome after non-cardiac surgery. Clin Chem Lab Med. 2017;55(1):145-153. doi: 10.1515/cclm-2016-0038.
8. El-Boghdadly K, Cook TM, Goodacre T, et al. SARS-CoV-2 infection, COVID-19 and timing of elective surgery: a multidisciplinary consensus statement on behalf of the Association of Anaesthetists, the Centre for Peri-operative Care, the Federation of Surgical Specialty Associations, the Royal College of Anaesthetists and the Royal College of Surgeons of England. Anaesthesia 2021. Epub 18 March. doi: 10.1111/anae.15464
9. Ortoleva J. Anesthetic Considerations for Recovered COVID-19 Patients. J Cardiothorac Vasc Anesth. 2021;35(2):376-377. doi: 10.1053/j.jvca.2020.10.032.
10. Singh AK, Singh R, Joshi SR, et al. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021 May 21. Epub-ahead-of-print. doi: 10.1016/j.dsx.2021.05.019